Cita APA (7a ed.)

J, X., N, L., X, J., L, C., JJ, C., & W, D. (2019). Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus. Dove Medical Press.

Cita Chicago Style (17a ed.)

J, Xie, Li N, Jiang X, Chai L, Chen JJ, y Deng W. Short-term Efficacy and Safety of Repaglinide Versus Glimepiride as Augmentation of Metformin in Treating Patients with Type 2 Diabetes Mellitus. Dove Medical Press, 2019.

Cita MLA (8a ed.)

J, Xie, et al. Short-term Efficacy and Safety of Repaglinide Versus Glimepiride as Augmentation of Metformin in Treating Patients with Type 2 Diabetes Mellitus. Dove Medical Press, 2019.